基础医学与临床 ›› 2018, Vol. 38 ›› Issue (8): 1173-1177.

• 短篇综述 • 上一篇    下一篇

氯胺酮抗围绝经期抑郁症的研究进展

吴杭玉,叶梅,张宜生   

  1. 宁波大学医学院糖尿病实验室
  • 收稿日期:2017-07-06 修回日期:2018-01-24 出版日期:2018-08-05 发布日期:2018-07-24
  • 通讯作者: 张宜生 E-mail:doctorzhangys@139.com
  • 基金资助:
    宁波市科技创新团队;李惠利东部医院专项

Research progress of antidepressant effect of ketamine on perimenopausal depression

  • Received:2017-07-06 Revised:2018-01-24 Online:2018-08-05 Published:2018-07-24

摘要: 围绝经期抑郁症是指妇女绝经前后的一段时期内出现的精神心理障碍。众多研究认为围绝经期抑郁症的发病机制与围绝经期生殖激素波动和单胺类神经递质水平改变有关。传统抗抑郁药很多,但常存在起效慢,疗效有限,且有相当比例的患者在经过治疗后出现残留症状和持续性功能障碍。而氯胺酮作为一种全身麻醉药,可通过拮抗NMDA受体、调节单胺类神经递质、增加脑源性神经营养因子、激活mTOR通路等多种信号途径对围绝经期抑郁症可起到快速、有效的抗抑郁作用。

关键词: 关键词:围绝经期, 抑郁症, 氯胺酮, 生殖激素, 单胺类神经递质

Abstract: Perimenopausal depression refers to women's mood disorders developed before and after menopause. Many studies have suggested that the occurrence of perimenopausal depression is associated with the fluctuation of perimenopausal reproductive hormone, alterations of monoamine neurotransmitter levels during the period of menopausal. Although there are many traditional antidepressants, they often onset slow, limited efficacy, and a considerable proportion of patients after treatment, still have residual symptoms and persistent dysfunction. As a general anesthetic, ketamine can act as a fast and effective treatment for perimenopausal depression by antagonizing NMDA receptors, modulating monoamine neurotransmitters, increasing brain-derived neurotrophic factor and activating mTOR pathway and other signaling pathways to exert anti-depressant effect.

Key words: Key Words: perimenopausal period, depression, ketamine, reproductive hormone, monoamine neurotransmitter